(Q33413352)

English

Effect of ropinirole on sleep outcomes in patients with restless legs syndrome: meta-analysis of pooled individual patient data from randomized controlled trials

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

0 references

Effect of ropinirole on sleep outcomes in patients with restless legs syndrome: meta-analysis of pooled individual patient data from randomized controlled trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

restless legs syndrome

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Richard A. Hansen

object named as

Richard A Hansen

1

0 references

Charity G Moore

object named as

Charity G Moore

3

0 references

author name string

Liping Song

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Alicia W Gilsenan

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Mimi M Kim

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Michael O Calloway

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Michael D Murray

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

0 references

publication date

1 March 2009

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Pharmacotherapy

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

255-262

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.3.255

21 January 2018

Restless legs syndrome prevalence and impact: REST general population study

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.3.255

21 January 2018

Restless legs syndrome symptoms in primary care: a prevalence study.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.3.255

21 January 2018

Prevalence of restless legs syndrome among men aged 18 to 64 years: an association with somatic disease and neuropsychiatric symptoms.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.3.255

21 January 2018

Self-reported depressive symptomatology, mood ratings, and treatment outcome in sleep disorders patients

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.3.255

21 January 2018

Epidemiology of restless legs syndrome: the current status.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.3.255

21 January 2018

Evaluating the quality of life of patients with restless legs syndrome.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.3.255

21 January 2018

An algorithm for the management of restless legs syndrome

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.3.255

21 January 2018

Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.3.255

21 January 2018

Ropinirole in the treatment of patients with restless legs syndrome: a US-based randomized, double-blind, placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.3.255

21 January 2018

Ropinirole is effective in the long-term management of restless legs syndrome: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.3.255

21 January 2018

Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.3.255

21 January 2018

Analysis of data from multiclinic trials

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.3.255

21 January 2018

Multicentre trials: a US regulatory perspective

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.3.255

21 January 2018

Psychometric properties of the Medical Outcomes Study Sleep measure

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.3.255

21 January 2018

The reliability, validity and responsiveness of the Restless Legs Syndrome Quality of Life questionnaire (RLSQoL) in a trial population

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.3.255

21 January 2018

A visitor's guide to effect sizes: statistical significance versus practical (clinical) importance of research findings.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.3.255

21 January 2018

Meta-analysis of the literature or of individual patient data: is there a difference?

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.3.255

21 January 2018

Prevalence of restless legs syndrome and periodic limb movement disorder in the general population

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.3.255

21 January 2018

Race, iron status and restless legs syndrome.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.3.255

21 January 2018

A sharper Bonferroni procedure for multiple tests of significance

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.3.255

21 January 2018

Identifiers

10.1592/PHCO.29.3.255

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33413352&oldid=1645015594"